Home »
Rulemaking » Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Document ID: EPA-HQ-OW-2008-0517-0019
Document Type: Public Submission
Agency: Environmental Protection Agency
Received Date: October 30 2008, at 02:54 PM Eastern Daylight Time
Date Posted: November 5 2008, at 12:00 AM Eastern Standard Time
Comment Start Date: August 12 2008, at 12:00 AM Eastern Standard Time
Comment Due Date: November 10 2008, at 11:59 PM Eastern Standard Time
Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Title: Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
View Attachment:
Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Title: Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
This is comment on Notice
Agency Information Collection Activities: Proposed Collection; Comment Request; Study of Unused Pharmaceuticals from Medical and Veterinary Facilities (New), EPA ICR Number 2316.01, OMB Control No. 2040-NEW
Attachments:
Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Title:
Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Title:
Comment submitted by Michael Garvin, Assistant Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Related Comments
View AllPublic Submission Posted: 08/26/2008 ID: EPA-HQ-OW-2008-0517-0010
Nov 10,2008 11:59 PM ET
Public Submission Posted: 08/29/2008 ID: EPA-HQ-OW-2008-0517-0011
Nov 10,2008 11:59 PM ET
Public Submission Posted: 10/27/2008 ID: EPA-HQ-OW-2008-0517-0016
Nov 10,2008 11:59 PM ET
Public Submission Posted: 11/04/2008 ID: EPA-HQ-OW-2008-0517-0018
Nov 10,2008 11:59 PM ET
Public Submission Posted: 11/05/2008 ID: EPA-HQ-OW-2008-0517-0019
Nov 10,2008 11:59 PM ET